These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 34814396)

  • 21. Prolonged post-ablation fever may predict one-year tumor recurrence in hepatocellular carcinoma after radiofrequency ablation.
    Ho PH; Teng W; Lin CC; Jeng WJ; Chen WT; Lin CY; Lin SM; Sheen IS
    Int J Hyperthermia; 2020; 37(1):1008-1015. PubMed ID: 32814458
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term Favorable Outcomes of Radiofrequency Ablation for Hepatocellular Carcinoma as an Initial Treatment: A Single-center Experience Over a 10-Year Period.
    Tsukamoto M; Yamashita YI; Imai K; Umezaki N; Yamao T; Kaida T; Mima K; Nakagawa S; Hashimoto D; Chikamoto A; Ishiko T; Baba H
    Anticancer Res; 2018 Feb; 38(2):1047-1052. PubMed ID: 29374739
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intrahepatic recurrence after percutaneous radiofrequency ablation of hepatocellular carcinoma: analysis of the pattern and risk factors.
    Kim YS; Rhim H; Cho OK; Koh BH; Kim Y
    Eur J Radiol; 2006 Sep; 59(3):432-41. PubMed ID: 16690240
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predisposing factors for recurrence of HBV-related small hepatocellular carcinoma after percutaneous radiofrequency ablation.
    Sohn W; Paik YH; Lee MW; Rhim H; Lim HK; Cho JY; Gwak GY; Choi MS; Lee JH; Koh KC; Paik SW; Yoo BC
    Scand J Gastroenterol; 2014 Mar; 49(3):373-80. PubMed ID: 24354931
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recurrence-free survival after radiofrequency ablation of hepatocellular carcinoma. A registry report of the impact of risk factors on outcome.
    Zytoon AA; Ishii H; Murakami K; El-Kholy MR; Furuse J; El-Dorry A; El-Malah A
    Jpn J Clin Oncol; 2007 Sep; 37(9):658-72. PubMed ID: 17766723
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combined resection and radiofrequency ablation versus transarterial embolization for intermediate-stage hepatocellular carcinoma: A propensity score matching study.
    Espinosa W; Liu YW; Wang CC; Lin CC; Wang JH; Lu SN; Hung CH
    J Formos Med Assoc; 2018 Mar; 117(3):197-203. PubMed ID: 28411877
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Efficacy and Therapeutic Outcome of Bipolar Radiofrequency Ablation for the Treatment for Hepatocellular Carcinoma in the Real-World Setting, Compared with Monopolar Radiofrequency Ablation Conducted during the Same Period.
    Tanaka T; Takata K; Kunimoto H; Fukuda H; Yamauchi R; Tsuchiya N; Inomata S; Yokoyama K; Morihara D; Takeyama Y; Shakado S; Sakisaka S; Hirai F
    Oncology; 2020; 98(12):859-868. PubMed ID: 32799203
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Topographical impact of hepatitis B-related hepatocellular carcinoma on local recurrence after radiofrequency ablation.
    Kim JS; Kim W; So YH; Yu SJ; Kim BG
    J Clin Gastroenterol; 2014 Jan; 48(1):66-72. PubMed ID: 23751848
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The 10-year Survival Analysis of Radiofrequency Ablation for Solitary Hepatocellular Carcinoma 5 cm or Smaller: Primary versus Recurrent HCC.
    Bai XM; Cui M; Yang W; Wang H; Wang S; Zhang ZY; Wu W; Chen MH; Yan K; Goldberg SN
    Radiology; 2021 Aug; 300(2):458-469. PubMed ID: 34003058
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Is serum endocan a sensitive biomarker for early recurrence of hepatocellular carcinoma after radiofrequency ablation?
    Omar SA; Attia NM; Sheir MI; Amer AS; El Shabrawy MM; Hasan BB
    Eur J Gastroenterol Hepatol; 2021 Jul; 33(7):1015-1022. PubMed ID: 33867440
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Meta-analysis of trans-hepatic artery chemoembolization combined with radiofrequency ablation versus transhepatic artery chemoembolization alone for recurrent liver cancer after hepatectomy.
    Ji B; Hao F; Wu X; Lu Z
    Asian J Surg; 2023 Apr; 46(4):1819-1821. PubMed ID: 36504155
    [No Abstract]   [Full Text] [Related]  

  • 32. Transarterial chemoembolization combined with radiofrequency ablation for solitary large hepatocellular carcinoma ranging from 5 to 7 cm: an 8-year prospective study.
    Long J; Wang H; Zhao P; Sheng SP; Qin-Sheng Shi ; Long M; Zheng JS
    Abdom Radiol (NY); 2020 Sep; 45(9):2736-2747. PubMed ID: 32533245
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Local recurrence and complications after percutaneous radiofrequency ablation of hepatocellular carcinoma: a retrospective cohort study focused on tumor location.
    Toshimori J; Nouso K; Nakamura S; Wada N; Morimoto Y; Takeuchi Y; Yasunaka T; Kuwaki K; Ohnishi H; Ikeda F; Shiraha H; Takaki A; Yamamoto K
    Acta Med Okayama; 2015; 69(4):219-26. PubMed ID: 26289913
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of combination therapy with transcatheter arterial chemoembolization and radiofrequency ablation for intermediate-stage hepatocellular carcinoma.
    Endo K; Kuroda H; Oikawa T; Okada Y; Fujiwara Y; Abe T; Sato H; Sawara K; Takikawa Y
    Scand J Gastroenterol; 2018 Dec; 53(12):1575-1583. PubMed ID: 30577723
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Albumin-bilirubin grade may determine the outcomes of patients with very early stage hepatocellular carcinoma after radiofrequency ablation therapy.
    Chen PC; Chiu NC; Su CW; Huang YH; Hou MC; Lin HC; Wu JC
    J Chin Med Assoc; 2019 Jan; 82(1):2-10. PubMed ID: 30839396
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aspartate aminotransferase-to-platelet ratio index for predicting late recurrence of hepatocellular carcinoma after radiofrequency ablation.
    Zhang X; Xin Y; Yang Y; Chen Y; Cao XJ; Wang Y; Fan Q; Zhou X; Li X
    Int J Hyperthermia; 2022; 39(1):437-445. PubMed ID: 35249443
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Predictive value of quantitative contrast-enhanced ultrasound in hepatocellular carcinoma recurrence after ablation.
    Gao Y; Zheng DY; Cui Z; Ma Y; Liu YZ; Zhang W
    World J Gastroenterol; 2015 Sep; 21(36):10418-26. PubMed ID: 26420968
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Thermal Injury-induced Hepatic Parenchymal Hypoperfusion: Risk of Hepatocellular Carcinoma Recurrence after Radiofrequency Ablation.
    Lee DH; Lee JM; Yoon JH; Kim YJ; Han JK
    Radiology; 2017 Mar; 282(3):880-891. PubMed ID: 27643670
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combination therapy with PD-1 blockade and radiofrequency ablation for recurrent hepatocellular carcinoma: a propensity score matching analysis.
    Wang X; Liu G; Chen S; Bi H; Xia F; Feng K; Ma K; Ni B
    Int J Hyperthermia; 2021 Oct; 38(1):1519-1528. PubMed ID: 34702122
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Small single perivascular hepatocellular carcinoma: comparisons of radiofrequency ablation and microwave ablation by using propensity score analysis.
    An C; Li WZ; Huang ZM; Yu XL; Han YZ; Liu FY; Wu SS; Yu J; Liang P; Huang J
    Eur Radiol; 2021 Jul; 31(7):4764-4773. PubMed ID: 33399908
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.